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List of Abbreviations 
 
 
AAV   Adeno-associated virus (AAV) 
AnkG   Ankyrin-G (AnkG) 
AAALAC  Assessment and Accreditation of Laboratory Animal Care (AAALAC) 
ARM   Autoinhibitory N-terminus region consisting of armadillo/HEAT motifs () 
AIS   Axon initial segment 
BiFC   Bimolecular fluorescence complementation 
BBB   Blood-brain barrier  
TIR  C-terminus Toll/Interleuken-1 receptor 
CNS   Central nervous system  
CSF   Cerebrospinal fluid  
CIS   Clinically isolated syndrome 
CFA   Complete Freund’s adjuvant  
DMT   Disease modifying therapies  
EAE   Experimental autoimmune encephalomyelitis  
GFP   Green fluorescent protein  
i.p.  Intraperitoneal  
K KO   nockout  
MRI  Magnetic resonance imaging  
MLS   Mitochondrial localization signal  
MS   Multiple sclerosis  
MBP   Myelin basic protein 
MOG   Myelin oligodendrocyte glycoprotein  
MAG   Myelin-associated glycoprotein  
MOBP  Myelin-associated oligodendrocytic basic protein  
NAD   Nicotinamide adenine dinucleotide 
NADase Nicotinamide adenine dinucleotide nucleosidase 
NMN   Nicotinamide mononucleotide  
NMNAT  Nicotinamide mononucleotide adenylyltransferase  
PPMS   Primary progressive MS  
PRMS  Progressive relapsing  
PLP   Proteolipid protein  
RRMS  Relapsing-remitting MS  
SARM1  Sterile alpha and TIR motif-containing 1 
SPMS   Secondary progressive MS  
TH17 cells  T helper 17 cells  
TLR   Toll-like receptor  
SAM   Sterile alpha motifs   
































































































Clinical score comparison of Sarm1-KO and wildtype littermates through chronic EAE course (42 
days post-induction).
EAE was actively induced in 6- to 10-week old Sarm1 [N = 15 (7F/8M) knockout ice and wild type 
littermates [N = 12 (7F/5M)]. Animals that did not manifest signs of EAE by day 14 post-induction 
were excluded. Mice were scored as follows: 0 – no overt signs of disease; 1 – limp tail or loss of 
righting reflex but not both; 2 – limp tail and loss of righting reflex; 3 – partial hind limb paralysis; 4 –



















































































































































Expression vectors Protein(s) expressed Expected size: kDa (a.a.)
1 pcDNA3.1-mCitrine Full length monomeric Citrine 27 (241)
2 pcDNA3.1-mCitrine.N172 N-terminal 172-amino-acid fragment of mCitrine (N172)  20 (172)
3 pcDNA3.1-mCitrine.C67 C-terminal 67-amino-acid fragment of mCitrine (C67) 7.5 (67)
4 pcDNA3.1-SARM1-
mCitrine.N172
SARM1 fused to N172 100 (913)
5 pcDNA3.1-SARM1-
mCitrine.C67
SARM1 fused to C67 80 (808)
6 pcDNA3.1-ΔNterm-
mCitrine.N172
SARM1 mutant lacking N-terminal autoinhibitory domain fused to N172 506  (55.5)
7 pcDNA3.1-ΔNterm-
mCitrine.C67
SARM1 mutant lacking N-terminal autoinhibitory domain fused to C67 401  (43)

























List	of	References	Bar-Or	A,	Fawaz	L,	Fan	B,	Darlington	P,	Rieger	A,	Ghorayeb	C,	Calabresi	P,	Waubant	E,	Hauser	S,	Zhang	J,	Smith	C.	Abnormal	B-cell	cytokine	responses	a	trigger	of	T-cell-mediated	disease	in	MS?.	Annals	of	Neurology	(2010)	67(4)	452-461		Barkhof	F,	Walderveen	M.	Characterization	of	tissue	damage	in	multiple	sclerosis	by	nuclear	magnetic	resonance.	Philosophical	Transactions	of	the	Royal	Society	of	London.	Series	B:	Biological	Sciences	(1999)	354(1390)	1675-1686		 Ben-Nun	A,	Wekerle	H,	Cohen	I.	Pillars	Article:	The	Rapid	Isolation	of	Clonable	Antigen-specific	T	Lymphocyte	Lines	Capable	of	Mediating	Autoimmune	Encephalomyelitis.	Eur	J	Immunol.	1981.11:	195-199.	Journal	of	immunology	(Baltimore,	Md.	:	1950)	(2017)	198(9)	3384-3388		Benusa	S,	George	N,	Sword	B,	DeVries	G,	Dupree	J.	Acute	neuroinflammation	induces	AIS	structural	plasticity	in	a	NOX2-dependent	manner.	Journal	of	neuroinflammation	(2017)	14(1)	116		Brazill	J,	Li	C,	Zhu	Y,	Zhai	R.	NMNAT:	It's	an	NAD+	synthase…	It's	a	chaperone…	It's	a	neuroprotector.	Current	opinion	in	genetics	&	development	(2017)	44	156-162		Cabello	N,	Gandía	J,	Bertarelli	D,	Watanabe	M,	Lluís	C,	Franco	R,	Ferré	S,	Luján	R,	Ciruela	F.	Metabotropic	glutamate	type	5,	dopamine	D2	and	adenosine	A2a	receptors	form	higher-order	oligomers	in	living	cells.	Journal	of	neurochemistry	(2009)	109(5)	1497-507		 Clark	K,	Josephson	A,	Benusa	S,	Hartley	R,	Baer	M,	Thummala	S,	Joslyn	M,	Sword	B,	Elford	H,	Oh	U,	Dilsizoglu-Senol	A,	Lubetzki	C,	Davenne	M,	DeVries	G,	Dupree	J.	Compromised	axon	initial	segment	integrity	in	EAE	is	preceded	by	microglial	reactivity	and	contact.	Glia	(2016)	64(7)	1190-1209		 Clark	K,	Sword	B,	Dupree	J.	Oxidative	Stress	Induces	Disruption	of	the	Axon	Initial	Segment.	ASN	neuro	(2017)	9(6)	1759091417745426		 Da	Mesquita	S,	Louveau	A,	Vaccari	A,	Smirnov	I,	Cornelison	R,	Kingsmore	K,	Contarino	C,	Onengut-Gumuscu	S,	Farber	E,	Raper	D,	Viar	K,	Powell	R,	Baker	W,	Dabhi	N,	Bai	R,	Cao	R,	Hu	S,	Rich	S,	Munson	J,	Lopes	M,	Overall	C,	Acton	S,	Kipnis	J.	Functional	aspects	of	meningeal	lymphatics	in	ageing	and	Alzheimer's	disease.	Nature	(2018)	560(7717)	185-191		Dargahi	N,	Katsara	M,	Tselios	T,	Androutsou	M,	Courten	M,	Matsoukas	J,	Apostolopoulos	V.	Multiple	Sclerosis:	Immunopathology	and	Treatment	Update.	Brain	Sciences	(2017)	7(7)		 Dendrou	C,	Fugger	L,	Friese	M.	Immunopathology	of	multiple	sclerosis.	Nature	Reviews	Immunology	(2015)	15(9)	545-558		 Dupree	J,	Girault	J,	Popko	B.	Axo-glial	interactions	regulate	the	localization	of	axonal	paranodal	proteins.	The	Journal	of	cell	biology	(1999)	147(6)	1145-52	
 38 
	 Ellwardt	E,	Zipp	F.	Molecular	mechanisms	linking	neuroinflammation	and	neurodegeneration	in	MS.	Experimental	Neurology	(2014)	262	8-17		 Encinas	J,	Wicker	L,	Peterson	L,	Mukasa	A,	Teuscher	C,	Sobel	R,	Weiner	H,	Seidman	C,	Seidman	J,	Kuchroo	V.	QTL	influencing	autoimmune	diabetes	and	encephalomyelitis	map	to	a	0.15-cM	region	containing	Il2.	Nature	Genetics	(1999)	21(2)	158-160		 Fekonja	O,	Avbelj	M,	Jerala	R.	Suppression	of	TLR	signaling	by	targeting	TIR	domain-containing	proteins.	Current	protein	&	peptide	science	(2012)	13(8)	776-88		 Filippi	M,	Bar-Or	A,	Piehl	F,	Preziosa	P,	Solari	A,	Vukusic	S,	Rocca	M.	Multiple	sclerosis.	Nature	Reviews	Disease	Primers	(2018)	4(1)	43		 Frischer	J,	Bramow	S,	Dal-Bianco	A,	Lucchinetti	C,	Rauschka	H,	Schmidbauer	M,	Laursen	H,	Sorensen	P,	Lassmann	H.	The	relation	between	inflammation	and	neurodegeneration	in	multiple	sclerosis	brains.	Brain	(2009)	132(5)	1175-1189		 Geisler	S,	Huang	S,	Strickland	A,	Doan	R,	Summers	D,	Mao	X,	Park	J,	DiAntonio	A,	Milbrandt	J.	Gene	therapy	targeting	SARM1	blocks	pathological	axon	degeneration	in	mice.	The	Journal	of	Experimental	Medicine	(2019)	216		 Gerdts	J,	Summers	D,	Sasaki	Y,	DiAntonio	A,	Milbrandt	J.	Sarm1-mediated	axon	degeneration	requires	both	SAM	and	TIR	interactions.	The	Journal	of	neuroscience	:	the	official	journal	of	the	Society	for	Neuroscience	(2013)	33(33)	13569-80		 Gilley	J,	Ribchester	R,	Coleman	M.	Sarm1	Deletion,	but	Not	WldS,	Confers	Lifelong	Rescue	in	a	Mouse	Model	of	Severe	Axonopathy.	Cell	reports	(2017)	21(1)	10-16	Girouard	M,	Bueno	M,	Julian	V,	Drake	S,	Byrne	A,	Fournier	A.	The	Molecular	Interplay	between	Axon	Degeneration	and	Regeneration.	Developmental	Neurobiology	(2018)	78(10)	978-990		Glatigny	S,	Bettelli	E.	Experimental	Autoimmune	Encephalomyelitis	(EAE)	as	Animal	Models	of	Multiple	Sclerosis	(MS).	Cold	Spring	Harbor	perspectives	in	medicine	(2018)	8(11)	a028977		 Hazelton	J,	Petrasheuskaya	M,	Fiskum	G,	Kristián	T.	Cyclophilin	D	is	expressed	predominantly	in	mitochondria	of	gamma-aminobutyric	acidergic	interneurons.	Journal	of	neuroscience	research	(2009)	87(5)	1250-9		 Henninger	N,	Bouley	J,	Sikoglu	E,	An	J,	Moore	C,	King	J,	Bowser	R,	Freeman	M,	Brown	R,	Jr.	Attenuated	traumatic	axonal	injury	and	improved	functional	outcome	after	traumatic	brain	injury	in	mice	lacking	Sarm1.	Brain	:	a	journal	of	neurology	(2016)	139(Pt	4)	1094-105		 Hu	C,	Grinberg	A,	Kerppola	T.	Visualization	of	Protein	Interactions	in	Living	Cells	Using	Bimolecular	Fluorescence	Complementation	(BiFC)	Analysis.	Current	Protocols	in	Cell	Biology	(2005)	29(1)	21.3.1-21.3.21		
 39 
J	Beaudoin	G,	Lee	S,	Singh	D,	Yuan	Y,	Ng	Y,	Reichardt	L,	Arikkath	J.	Culturing	pyramidal	neurons	from	the	early	postnatal	mouse	hippocampus	and	cortex.	Nat	Protoc.	2012	Sep;7(9):1741-54.		 Kaiko	G,	Horvat	J,	Beagley	K,	Hansbro	P.	Immunological	decision-making:	how	does	the	immune	system	decide	to	mount	a	helper	T-cell	response?.	Immunology	(2008)	123(3)	326-38		 Kaskow	B,	Baecher-Allan	C.	Effector	T	Cells	in	Multiple	Sclerosis.	Cold	Spring	Harbor	perspectives	in	medicine	(2018)	8(4)	a029025		 Kim	Y,	Zhou	P,	Qian	L,	Chuang	J,	Lee	J,	Li	C,	Iadecola	C,	Nathan	C,	Ding	A.	MyD88-5	links	mitochondria,	microtubules,	and	JNK3	in	neurons	and	regulates	neuronal	survival.	The	Journal	of	Experimental	Medicine	(2007)	204(9)	2063-2074		 Leterrier	C.	The	Axon	Initial	Segment:	An	Updated	Viewpoint.	The	Journal	of	neuroscience	:	the	official	journal	of	the	Society	for	Neuroscience	(2018)	38(9)	2135-2145		 Louveau	A,	Herz	J,	Alme	M,	Salvador	A,	Dong	M,	Viar	K,	Herod	S,	Knopp	J,	Setliff	J,	Lupi	A,	Da	Mesquita	S,	Frost	E,	Gaultier	A,	Harris	T,	Cao	R,	Hu	S,	Lukens	J,	Smirnov	I,	Overall	C,	Oliver	G,	Kipnis	J.	CNS	lymphatic	drainage	and	neuroinflammation	are	regulated	by	meningeal	lymphatic	vasculature.	Nature	neuroscience	(2018)	21(10)	1380-1391		 Mack	T,	Reiner	M,	Beirowski	B,	Mi	W,	Emanuelli	M,	Wagner	D,	Thomson	D,	Gillingwater	T,	Court	F,	Conforti	L,	Fernando	F,	Tarlton	A,	Andressen	C,	Addicks	K,	Magni	G,	Ribchester	R,	Perry	V,	Coleman	M.	Wallerian	degeneration	of	injured	axons	and	synapses	is	delayed	by	a	Ube4b/Nmnat	chimeric	gene.	Nature	Neuroscience	(2001)	4(12)	1199-1206		Massoll	C,	Mando	W,	Chintala	S.	Excitotoxicity	upregulates	SARM1	protein	expression	and	promotes	Wallerian-like	degeneration	of	retinal	ganglion	cells	and	their	axons.	Investigative	ophthalmology	&	visual	science	(2013)	54(4)	2771-80		 Mendel	I,	de	Rosbo	N,	Ben-Nun	A.	A	myelin	oligodendrocyte	glycoprotein	peptide	induces	typical	chronic	experimental	autoimmune	encephalomyelitis	in	H-2b	mice:	Fine	specificity	and	T	cell	receptor	Vβ	expression	of	encephalitogenic	T	cells.	European	Journal	of	Immunology	(1995)	25(7)	1951-1959		 Moreno	J,	Miranda-Azpiazu	P,	García-Bea	A,	Younkin	J,	Cui	M,	Kozlenkov	A,	Ben-Ezra	A,	Voloudakis	G,	Fakira	A,	Baki	L,	Ge	Y,	Georgakopoulos	A,	Morón	J,	Milligan	G,	López-Giménez	J,	Robakis	N,	Logothetis	D,	Meana	J,	González-Maeso	J.	Allosteric	signaling	through	an	mGlu2	and	5-HT2A	heteromeric	receptor	complex	and	its	potential	contribution	to	schizophrenia.	Science	signaling	(2016)	9(410)	ra5		 Neukomm	L,	Burdett	T,	Seeds	A,	Hampel	S,	Coutinho-Budd	J,	Farley	J,	Wong	J,	Karadeniz	Y,	Osterloh	J,	Sheehan	A,	Freeman	M.	Axon	Death	Pathways	Converge	on	Axundead	to	Promote	Functional	and	Structural	Axon	Disassembly.	Neuron	(2017)	95(1)		
 40 
Osterloh	J,	Yang	J,	Rooney	T,	Fox	A,	Adalbert	R,	Powell	E,	Sheehan	A,	Avery	M,	Hackett	R,	Logan	M,	MacDonald	J,	Ziegenfuss	J,	Milde	S,	Hou	Y,	Nathan	C,	Ding	A,	Brown	R,	Conforti	L,	Coleman	M,	Tessier-Lavigne	M,	Züchner	S,	Freeman	M,	Freeman	M.	dSarm/Sarm1	is	required	for	activation	of	an	injury-induced	axon	death	pathway.	Science	(New	York,	N.Y.)	(2012)	337(6093)	481-4		 Palanichamy	A,	Jahn	S,	Nickles	D,	Derstine	M,	Abounasr	A,	Hauser	S,	Baranzini	S,	Leppert	D,	von	Büdingen	H.	Rituximab	efficiently	depletes	increased	CD20-expressing	T	cells	in	multiple	sclerosis	patients.	Journal	of	immunology	(Baltimore,	Md.	:	1950)	(2014)	193(2)	580-586		 Peach	M,	Marsh	N,	MacPhee	D.	Protein	Solubilization:	Attend	to	the	Choice	of	Lysis	Buffer.	Humana	Press,	Totowa,	NJ,	(2012),	37-47		 Peters	O,	Lewis	E,	Osterloh	J,	Weiss	A,	Salameh	J,	Metterville	J,	Brown	R,	Freeman	M.	Loss	of	Sarm1	does	not	suppress	motor	neuron	degeneration	in	the	SOD1G93A	mouse	model	of	amyotrophic	lateral	sclerosis.	Human	molecular	genetics	(2018)	27(21)	3761-3771		 Pomicter	A,	Shroff	S,	Fuss	B,	Sato-Bigbee	C,	Brophy	P,	Rasband	M,	Bhat	M,	Dupree	J.	Novel	forms	of	neurofascin	155	in	the	central	nervous	system:	alterations	in	paranodal	disruption	models	and	multiple	sclerosis.	Brain	:	a	journal	of	neurology	(2010)	133(Pt	2)	389-405		 Prevention	of	vincristine-induced	peripheral	neuropathy	by	genetic	deletion	of	SARM1	in	mice.	Geisler	S,	Doan	R,	Strickland	A,	Huang	X,	Milbrandt	J,	DiAntonio	A.	Brain	:	a	journal	of	neurology	(2016)	139(Pt	12)	3092-3108		 Raddassi	K,	Kent	S,	Yang	J,	Bourcier	K,	Bradshaw	E,	Seyfert-Margolis	V,	Nepom	G,	Kwok	W,	Hafler	D.	Increased	frequencies	of	myelin	oligodendrocyte	glycoprotein/MHC	class	II-binding	CD4	cells	in	patients	with	multiple	sclerosis.	Journal	of	immunology	(Baltimore,	Md.	:	1950)	(2011)	187(2)	1039-46		 Ryan	B.	Griggs,	Leonid	M.	Yermakov,	Keiichiro	Susuki.	Formation	and	disruption	of	functional	domains	in	myelinated	CNS	axons.	Neuroscience	Research,Volume	116,2017,Pages	77-87,ISSN	0168-0102		 Sato-Bigbee	C,	Pal	S,	Chu	A.	Different	Neuroligands	and	Signal	Transduction	Pathways	Stimulate	CREB	Phosphorylation	at	Specific	Developmental	Stages	Along	Oligodendrocyte	Differentiation.	Journal	of	Neurochemistry	(1999)	72(1)	139-147		 Schultz	V,	van	der	Meer	F,	Wrzos	C,	Scheidt	U,	Bahn	E,	Stadelmann	C,	Brück	W,	Junker	A.	Acutely	damaged	axons	are	remyelinated	in	multiple	sclerosis	and	experimental	models	of	demyelination.	Glia	(2017)	65(8)	1350-1360		Singh	S,	Dallenga	T,	Winkler	A,	Roemer	S,	Maruschak	B,	Siebert	H,	Brück	W,	Stadelmann	C.	Relationship	of	acute	axonal	damage,	Wallerian	degeneration,	and	clinical	disability	in	multiple	sclerosis.	Journal	of	neuroinflammation	(2017)	14(1)	57		
 41 
Summers	D,	Gibson	D,	DiAntonio	A,	Milbrandt	J.	SARM1-specific	motifs	in	the	TIR	domain	enable	NAD+	loss	and	regulate	injury-induced	SARM1	activation.	Proceedings	of	the	National	Academy	of	Sciences	of	the	United	States	of	America	(2016)	113(41)	E6271-E6280		 Trapp	B,	Peterson	J,	Ransohoff	R,	Rudick	R,	Mörk	S,	Bö	L.	Axonal	Transection	in	the	Lesions	of	Multiple	Sclerosis.	New	England	Journal	of	Medicine	(1998)	338(5)	278-285		 Trapp	B,	Ransohoff	R,	Rudick	R.	Axonal	pathology	in	multiple	sclerosis:	relationship	to	neurologic	disability.	Current	opinion	in	neurology	(1999)	12(3)	295-302		 Turkiew	E,	Falconer	D,	Reed	N,	Höke	A.	Deletion	of	Sarm1	gene	is	neuroprotective	in	two	models	of	peripheral	neuropathy.	Journal	of	the	peripheral	nervous	system	:	JPNS	(2017)	22(3)	162		 van	Langelaar	J,	van	der	Vuurst	de	Vries	R,	Janssen	M,	Wierenga-Wolf	A,	Spilt	I,	Siepman	T,	Dankers	W,	Verjans	G,	de	Vries	H,	Lubberts	E,	Hintzen	R,	van	Luijn	M.	T	helper	17.1	cells	associate	with	multiple	sclerosis	disease	activity:	perspectives	for	early	intervention.	Brain	:	a	journal	of	neurology	(2018)	141(5)	1334-1349		 Vogt	J,	Paul	F,	Aktas	O,	Müller-Wielsch	K,	Dörr	J,	Dörr	S,	Bharathi	B,	Glumm	R,	Schmitz	C,	Steinbusch	H,	Raine	C,	Tsokos	M,	Nitsch	R,	Zipp	F.	Lower	motor	neuron	loss	in	multiple	sclerosis	and	experimental	autoimmune	encephalomyelitis.	Annals	of	Neurology	(2009)	66(3)	310-322		 Wallin	M,	Culpepper	W,	Campbell	J,	Nelson	L,	Langer-Gould	A,	Marrie	R,	Cutter	G,	Kaye	W,	Wagner	L,	Tremlett	H,	Buka	S,	Dilokthornsakul	P,	Topol	B,	Chen	L,	LaRocca	N.	The	prevalence	of	MS	in	the	United	States:	A	population-based	estimate	using	health	claims	data.	US	Multiple	Sclerosis	Prevalence	Workgroup.	Neurology	(2019)	92(10)	e1029-e1040		 Wekerle	H.	B	cells	in	multiple	sclerosis.	Autoimmunity	(2017)	50(1)	57-60			 							
 42 
Vita		Kenneth	Edward	Viar	was	born	on	May	8th,	1988,	in	Madison	Heights,	Virginia.	He	graduated	from	Virginia	Tech	in	the	spring	of	2010	and	earned	a	Bachelor	of	Science	degree	with	a	major	in	Biological	Sciences.	In	2011,	he	began	work	in	various	research	disciplines	at	the	University	of	Virginia.	First,	he	was	in	the	department	of	Molecular	Physiology	and	Biophysics	and	studied	the	structure	and	function	of	the	tonB-dependent	membrane	transport	system	of	gram-negative	bacteria.	In	2012,	he	joined	the	laboratory	of	Professor	Patrice	Guyenet	within	the	department	of	Pharmacology	where	he	helped	to	explore	the	autonomic	network	architecture	of	the	medulla,	specifically	in	the	C1	and	RTN	neurons.	For	four	years	he	studied	how	these	neuronal	populations	augment	blood	pressure,	respiration,	and	immune	function	in	various	conditions	and	states	of	consciousness	within	the	context	of	hypertension	and	obstructive	sleep	apnea.	In	2016,	he	joined	the	laboratory	of	Professor	Jonathan	Kipnis	of	the	Brain	Immunology	Glia	Center	at	UVA.	There	he	worked	on	projects	that	characterized	the	meningeal	lymphatic	vasculature	and	its	role	in	neurodegenerative	disease	pathogenesis.	These	studies	defined	the	paradigms	by	which	these	lymphatic	vessels	permit	peripheral	immune	surveillance	of	the	CNS	during	neuroinflammatory	disorders,	as	well	as	the	relationship	between	the	perivascular	system	and	lymphatic	vasculature	in	the	context	of	CNS	perfusion	in	Alzheimer’s	disease	and	aging	models.		 							
 
